# South Korea Transradial Access Devices Market

> South Korea Transradial Access Devices Market Research Report By Product (Catheters, Guidewires), By Application (Drug Administration, Blood Transfusion), By Disease Area (Cardiovascular Disease, Cancer, Strokes), and By End User (Hospitals, Clinics) - Growth & Industry Forecast 2025 To 2035

- **Forecast Period:** 2025 - 2035
- **CAGR:** 7.02%
- **2024:** $ 43.15 Million
- **2025:** $ 46.18 Million
- **2035:** $ 91.01 Million
- **Key Players:** Terumo Corporation (JP), Boston Scientific Corporation (US), Medtronic plc (IE), Abbott Laboratories (US), B. Braun Melsungen AG (DE), Cardinal Health, Inc. (US), Johnson & Johnson (US), Cook Medical Incorporated (US)

**Report ID:** MRFR/HC/54314-HCR · **Pages:** 200 · **Author:** Rahul Gotadki · **Last Updated:** February 06, 2026

**URL:** https://www.marketresearchfuture.com/reports/south-korea-transradial-access-devices-market-56080

---

## Market Summary

## **South Korea Transradial Access Devices Market Overview**

As per MRFR analysis, the South Korea Transradial Access Devices Market Size was estimated at 40.34 (USD Million) in 2023. The South Korea Transradial Access Devices Market Industry is expected to grow from 43.25(USD Million) in 2024 to 95 (USD Million) by 2035. The South Korea Transradial Access Devices Market CAGR (growth rate) is expected to be around 7.416% during the forecast period (2025 - 2035).

### **Key South Korea Transradial Access Devices Market Trends Highlighted**

Significant trends in the South Korea Transradial Access Devices Market are being driven by improvements in medical treatment and rising patient demand for less invasive procedures. Since the South Korean healthcare system is renowned for its creative methods and excellent medical care, transradial access is becoming more and more accepted as a safer and more comfortable alternative to femoral access. A growing understanding of the advantages of transradial procedures—which frequently lead to fewer complications and quicker recovery times—among patients and healthcare providers supports this change.

The continuous focus on patient comfort and safety, which complements the South Korean government's efforts to improve healthcare services, is one of the main market drivers. In order to encourage hospitals and clinics to accept cutting-edge medical choices, the government has been aggressively pushing technology adoption in the healthcare industry. Furthermore, the need for improved treatment approaches is being driven by the rising prevalence of cardiovascular disorders in South Korea, which makes transradial access devices crucial instruments for medical professionals.

Opportunities in the South Korean market are found in the creation of new technologies that enhance transradial access devices' functionality and usability. Both people and healthcare practitioners may be drawn to more effective solutions that result from innovations in materials and designs.Furthermore, healthcare facilities have the chance to broaden their service offerings due to the growing trend toward outpatient operations and quicker recovery times. More funds have recently been allocated to medical staff training programs in the application of transradial procedures, guaranteeing that practitioners are prepared to provide the best possible care.

The ultimate objective of enhancing patient outcomes and conforming to global best practices in interventional cardiology is enhanced by this emphasis on skill development. The South Korean market for transradial access devices is expected to continue expanding due to these changing trends and strong healthcare regulations.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

## **South Korea Transradial Access Devices Market Drivers**

### **Increase in Cardiovascular Diseases**

The South Korea Transradial Access Devices Market Industry is driven significantly by the rising prevalence of cardiovascular diseases. According to the Korean Society of Cardiology, cardiovascular diseases are the leading cause of death in South Korea, with over 30,000 fatalities reported annually. This alarming statistic reflects a broader trend wherein the number of patients requiring angioplasties and stenting procedures is increasing, leading to a higher demand for transradial access devices.

Furthermore, advancements in these devices are making the procedures safer and more attractive to healthcare providers, thus amplifying their adoption. Major hospitals in South Korea, such as Seoul National University Hospital, are increasingly implementing transradial access methods, citing reduced complications and faster recovery times for patients, which further propels the market growth.

### **Technological Advancements in Device Design**

Innovations in the design and functionality of transradial access devices are propelling the South Korea Transradial Access Devices Market Industry forward. Manufacturers are investing heavily in Research and Development to enhance device safety and usability. For instance, companies like Medtronic and Terumo Corporation are developing devices equipped with advanced materials that are not only lighter but also designed to improve patient ergonomics.

The Ministry of Food and Drug Safety in South Korea is also noted for expediting the approval process for these novel technologies, which allows for quicker market entry and a faster response to medical needs. The increased efficiency and effectiveness of these devices are aimed to correlate with improved patient outcomes, thus establishing a balanced growth trajectory for the market.

### **Focus on Minimally Invasive Procedures**

The transition toward minimally invasive surgical techniques in South Korea is another crucial driver for the South Korea Transradial Access Devices Market Industry. As healthcare providers strive to improve patient outcomes and reduce recovery times, there is a growing preference for procedures that cause less trauma to the body. According to the Korean Ministry of Health and Welfare, minimally invasive surgeries are linked with shorter hospital stays and lower healthcare costs.

This shift in preference supports the increased use of transradial access devices, as they are inherently less invasive than traditional femoral approaches. Additionally, leading medical institutions, like Asan Medical Center, are actively training more professionals in these techniques, which will further drive adoption rates of transradial access devices.

## **South Korea Transradial Access Devices Market Segment Insights**

### **Transradial Access Devices Market Product Insights**

The South Korea Transradial Access Devices Market is characterized by its diverse product offerings, primarily focusing on categories such as Catheters and Guidewires. Catheters play a pivotal role in facilitating minimally invasive procedures, allowing for efficient access to the vascular system. Their increasing utilization in interventional cardiology reflects a significant trend towards adopting less traumatic medical procedures, which in turn is driven by the rising awareness of patient comfort and faster recovery times. Additionally, advancements in catheter technology, including the development of biocompatible materials and specialized coatings, enhance their performance and safety, contributing to market growth.

Guidewires, another essential component of the Transradial Access Devices Market, hold a critical position in enabling the precise navigation of catheters through complex vascular pathways. The demand for guidewires has surged alongside the growth of diagnostic and therapeutic procedures, underpinning the importance of these devices in ensuring successful outcomes. Enhanced designs focused on deliverability and torqueability enable healthcare professionals to perform complex procedures with greater confidence and success rates. The continuous evolution of guidewire technology signifies its indispensable role in the overall performance of transradial access procedures.

Overall, these product categories within the South Korea Transradial Access Devices Market demonstrate robust growth potential fueled by technological innovations, increased procedural volumes in the healthcare sector, and the growing preference for procedures that minimize trauma and improve recovery times. Such dynamics suggest a promising future for these devices, as they align with the persistent push towards improved patient-centered care in South Korea's advanced healthcare landscape.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

### **Transradial Access Devices Market Application Insights**

The South Korea Transradial Access Devices Market, particularly within the Application segment, is witnessing notable developments. This segment comprises critical functions such as Drug Administration and Blood Transfusion, which play vital roles in improving patient outcomes. Transradial access has gained traction in South Korea due to its lower complication rates and enhanced recovery times, promoting its integration into various medical protocols. The Drug Administration application is particularly significant as it facilitates efficient medication delivery, addressing the growing demand for minimally invasive procedures.

Blood Transfusion also dominates this landscape, as the need for safe and efficient blood delivery systems remains high amid increasing surgical procedures. As healthcare facilities emphasize patient safety and comfort, the demand for these applications is expected to rise, driven by advancements in technology and patient care practices. Overall, the Application segment illustrates a robust trajectory, indicating the importance of continued investments and innovations within these areas to cater to the evolving healthcare landscape in South Korea.

### **Transradial Access Devices Market Disease Area Insights**

The South Korea Transradial Access Devices Market, particularly in the Disease Area segment, is significant due to the increasing prevalence of various health conditions such as cardiovascular diseases, cancer, and strokes. Cardiovascular disease remains a major health issue in South Korea, driven by factors such as lifestyle changes and an aging population. This has led to a growing demand for transradial access devices that facilitate less invasive procedures, improving patient outcomes and recovery times.

Cancer is also a critical area, with rising incidence rates prompting advancements in treatment methods that rely on effective patient access solutions.Moreover, strokes are a leading cause of long-term disability, emphasizing the need for efficient medical interventions through transradial techniques. As healthcare systems embrace minimally invasive approaches, the importance of these disease areas in shaping the South Korea Transradial Access Devices Market is clear, with ongoing innovation and adaptation to meet patient and clinician needs.

The market trends reflect an alignment with global healthcare improvements and policies aimed at enhancing medical access and quality of care, which are pivotal for ongoing growth in the market.

### **Transradial Access Devices Market End User Insights**

The End User segment of the South Korea Transradial Access Devices Market is primarily dominated by Hospitals and Clinics, which play a crucial role in the healthcare ecosystem. Hospitals serve as the main venues for various interventional procedures that utilize transradial access devices, as they are equipped with specialized staff and advanced technology to perform complex vascular interventions. Clinics also contribute significantly, offering outpatient services that facilitate quicker access to patients needing less invasive procedures. The increased focus on patient-centered care and the growing preference for minimally invasive techniques in these settings underlines their importance in the market.

The rising prevalence of cardiovascular diseases in South Korea further drives the demand for transradial access devices as both Hospitals and Clinics seek efficient solutions to enhance patient outcomes. Moreover, advanced training programs and improved procedural protocols are being adopted, ensuring that healthcare providers can effectively utilize these devices. With hospitals and clinics continuously evolving to meet the changing healthcare landscape, their pivotal role in the South Korea Transradial Access Devices Market remains pronounced, reflecting a commitment to enhancing patient care and procedural efficiency.

## **South Korea Transradial Access Devices Market Key Players and Competitive Insights**

The competitive insights of the South Korea Transradial Access Devices Market highlight a dynamic landscape characterized by the presence of numerous players who are innovating and enhancing their offerings to meet the evolving demands of healthcare providers and patients. Transradial access devices have gained traction due to their advantages in reducing complications related to traditional access methods. The market is seeing an influx of advanced technologies, including improved angiographic techniques and smart devices, contributing to the overall growth and competition within the sector.

Companies are investing in research and development to create innovative solutions that enhance patient outcomes while also focusing on regulatory compliance and expanding their market share through strategic partnerships and collaborations. As the market continues to evolve, understanding the competitive dynamics and regional strengths becomes crucial for stakeholders looking to establish a foothold in this sector.

Abbott stands out in the South Korea Transradial Access Devices Market with its commitment to delivering high-quality products and ensuring favorable clinical outcomes for patients. The company has established a strong market presence through its extensive distribution network and collaborations with healthcare institutions. Abbott's strength lies in its comprehensive portfolio of transradial access devices, which are designed to optimize vascular access and improve procedural efficiency. The company’s focus on innovation allows it to continually adapt to the needs of the healthcare landscape, making it a formidable player in the market.

Furthermore, Abbott's robust brand reputation, coupled with its dedication to patient safety and education, has solidified its position as a trusted provider among medical professionals in South Korea.

Avinger is another key player in the South Korea Transradial Access Devices Market, known for its pioneering technology in the field of vascular access. The company specializes in developing advanced imaging and access devices that enhance the precision and safety of transradial procedures. Avinger's key products are designed to provide real-time imaging capabilities, which significantly improve procedural outcomes. Its market presence is bolstered by strategic partnerships that facilitate broader distribution and integration of its products into local healthcare facilities. Avinger's strengths lie in its innovative approach to device development and a commitment to enhancing clinical efficiency.

The company has also engaged in mergers and acquisitions to strengthen its product offerings and expand its market reach, thereby increasing its competitiveness in the South Korean market.

### **Key Companies in the South Korea Transradial Access Devices Market Include:**

- Abbott
- Avinger
- [Medtronic](https://www.medtronic.com/en-us/healthcare-professionals/products.html)
- Stryker
- Johnson & Johnson
- Terumo
- Comedica
- Cardinal Health
- AngioDynamics
- Merit Medical Systems
- Create Medic
- Boston Scientific
- Vascular Solutions
- B. Braun Melsungen
- Cook Medical

### **South Korea Transradial Access Devices Market Industry Developments**

In South Korea, the Transradial Access Devices Market has recently experienced several notable developments. As of September 2023, Abbott launched a new line of radial access devices designed for enhanced patient outcomes in catheterizations, indicating a shift towards less invasive techniques in cardiovascular procedures. Meanwhile, Medtronic focused on expanding its product portfolio with innovative designs aimed at improving procedural efficiency. The market has seen a strong uptick due to growing demand for minimally invasive surgery options, which has spurred competition among major players like Stryker and Boston Scientific.

Furthermore, there have been significant investments in Research and Development efforts, with Terumo and AngioDynamics making strides in advanced technologies for transradial access. In addition, notable acquisitions are shaping the landscape merger between Merit Medical Systems and a prominent South Korean device firm in June 2023 is poised to enhance market share and capabilities. Overall, the South Korea Transradial Access Devices Market remains dynamic, with companies striving to leverage technological advancements while adapting to regulatory changes and increased healthcare demands.

## **South Korea Transradial Access Devices Market Segmentation Insights**

### **Transradial Access Devices Market Product Outlook**

- Catheters
- [Guidewires](../../../reports/guidewires-market-11544)

### **Transradial Access Devices Market Application Outlook**

- Drug Administration
- Blood Transfusion

### **Transradial Access Devices Market Disease Area Outlook**

- Cardiovascular Disease
- Cancer
- Strokes

### **Transradial Access Devices Market End User Outlook**

- Hospitals
- Clinics

## Market Drivers

### Increasing Cardiovascular Disease Prevalence

The rising incidence of cardiovascular diseases in South Korea is a primary driver for the transradial access-devices market. As the population ages, the demand for minimally invasive procedures increases, leading to a greater need for transradial access devices. Reports indicate that cardiovascular diseases account for approximately 30% of all deaths in the country, prompting healthcare providers to adopt advanced technologies. This trend is likely to continue, as the healthcare system seeks to improve patient outcomes and reduce recovery times. The transradial access-devices market is expected to benefit from this growing demand, as these devices facilitate safer and more efficient procedures, aligning with the healthcare sector's focus on enhancing patient care.

### Technological Innovations in Medical Devices

Ongoing technological innovations in medical devices are significantly influencing the transradial access-devices market. The introduction of advanced materials and designs enhances the performance and safety of these devices, making them more appealing to healthcare professionals. For instance, the development of ultra-thin catheters and improved hemostatic devices has led to better patient outcomes and reduced complications. In South Korea, the market for medical devices is projected to reach approximately $10 billion by 2026, with a substantial portion attributed to transradial access technologies. This growth reflects the increasing investment in research and development, which is crucial for maintaining competitiveness in the healthcare sector.

### Rising Demand for Minimally Invasive Procedures

The growing preference for minimally invasive procedures among patients and healthcare providers is a significant driver for the transradial access-devices market. These procedures are associated with reduced pain, shorter recovery times, and lower risk of complications, making them increasingly popular. In South Korea, the healthcare system is adapting to this trend, with a reported increase of over 20% in the number of procedures utilizing transradial access in recent years. This shift not only enhances patient satisfaction but also aligns with the broader goals of healthcare efficiency and cost-effectiveness. As a result, the transradial access-devices market is likely to experience sustained growth as more facilities adopt these techniques.

### Supportive Healthcare Policies and Reimbursement

Supportive healthcare policies and reimbursement frameworks in South Korea are fostering growth in the transradial access-devices market. The government has been actively promoting the adoption of advanced medical technologies through favorable reimbursement rates and incentives for healthcare providers. This approach encourages hospitals to invest in transradial access devices, as they can offer these services without incurring significant financial burdens. Furthermore, the Ministry of Health and Welfare has recognized the importance of improving cardiovascular care, which may lead to increased funding for related technologies. As a result, the transradial access-devices market is poised for expansion, driven by a conducive regulatory environment that supports innovation and accessibility.

### Growing Awareness and Education Among Healthcare Professionals

The increasing awareness and education among healthcare professionals regarding the benefits of transradial access techniques are driving the market forward. Training programs and workshops are being implemented across South Korea to enhance the skills of medical practitioners in using these devices effectively. This educational push is crucial, as it not only improves the proficiency of healthcare providers but also instills confidence in the use of transradial access methods. As more professionals become adept at these techniques, the adoption rate is likely to rise, further propelling the transradial access-devices market. The emphasis on continuous professional development in the medical field is expected to yield positive outcomes for patient care and procedural success.

## Future Outlook

The [Transradial Access Devices Market](https://www.marketresearchfuture.com/reports/transradial-access-devices-market-6061) is projected to grow at a 7.02% CAGR from 2025 to 2035, driven by technological advancements and increasing procedural adoption.

**New opportunities:**

- Development of advanced hemostatic devices for improved patient outcomes.
- Expansion of telehealth services for remote monitoring of transradial procedures.
- Partnerships with hospitals for exclusive supply agreements on access devices.

By 2035, the market is expected to achieve substantial growth and innovation.

## Segment Insights

### By Product: Guidewires (Largest) vs. Catheters (Fastest-Growing)

In the South Korea transradial access-devices market, the distribution of market share among segment values shows that guidewires hold the largest share, reflecting their critical role in various interventional procedures. Catheters, although they may hold a smaller share, are rapidly gaining traction due to increasing demand for minimally invasive procedures, highlighting the evolving preferences in medical practices.

The growth trends for these segments indicate that while guidewires remain essential and widely adopted, catheters are emerging as the fastest-growing due to technological advancements and increased procedural volume. Factors such as a growing elderly population, advancements in healthcare technology, and rising awareness of transradial access benefits drive this growth, shaping a dynamic competitive landscape in the South Korea transradial access-devices market.

Guidewires: Dominant vs. Catheters: Emerging

Guidewires are currently the dominant force within the South Korea transradial access-devices market, favored for their reliability and functionality in navigating vascular systems during various procedures. They are designed to be highly flexible yet sturdy, allowing for precise maneuvering, which is crucial for successful interventions. On the other hand, catheters are rapidly emerging as a significant segment, capitalizing on innovative designs and materials that enhance patient comfort and procedural efficiency. The rising inclination towards minimally invasive surgeries has placed catheters in the spotlight, driving their growth as healthcare providers increasingly turn to devices that facilitate quicker recovery times and reduced patient risk.

### By Application: Drug Administration (Largest) vs. Blood Transfusion (Fastest-Growing)

In the South Korea transradial access-devices market, the application of Drug Administration holds the largest market share, reflecting a strong preference among healthcare providers due to its critical role in effective patient treatment. Blood Transfusion, while smaller in overall market share, is rapidly gaining traction, indicating a shift in focus towards enhancing transfusion processes. This dynamic showcases a diverse application landscape, where both segments cater to essential healthcare needs.

Growth trends for these applications are driven by increasing patient populations and advancements in healthcare technologies. Drug Administration is propelled by a focus on precise medication delivery and an uptick in chronic disease management. Conversely, Blood Transfusion is expanding due to rising awareness of blood donation and improvements in transfusion safety, making it the fastest-growing segment within the market.

Drug Administration (Dominant) vs. Blood Transfusion (Emerging)

Drug Administration stands out as the dominant application in the South Korea transradial access-devices market, offering reliable and efficient methods for delivering medications directly into the bloodstream. Its established practices and integration into various treatment protocols position it as a backbone for many therapeutic procedures. In contrast, Blood Transfusion is emerging as a vital application, driven by increasing healthcare demands and innovative transfusion technologies that enhance patient safety and outcomes. Both segments showcase significant potential; Drug Administration continues to benefit from established protocols and reliance within the healthcare system, while Blood Transfusion is expected to witness robust growth as new technologies and increased awareness promote its adoption.

### By Disease Area: Cardiovascular Disease (Largest) vs. Cancer (Fastest-Growing)

In the South Korea transradial access-devices market, the distribution among major disease areas reveals that cardiovascular disease holds the largest market share, driven by a high prevalence of heart-related conditions. Cancer and strokes follow but with a significantly smaller presence, indicating that while these areas are important, cardiovascular interventions predominantly shape the market dynamics. This concentration on cardiovascular disease highlights the need for effective transradial access devices tailored for cardiac procedures, resulting in streamlined healthcare processes.

In recent years, the market has seen a significant push towards innovation in cancer treatment methodologies, establishing it as the fastest-growing segment. Factors driving this growth include an aging population, enhanced diagnostic techniques, and an increase in the awareness of cancer's impact. Consequently, transradial access devices designed for oncology procedures are emerging, indicating a shift in focus that reflects broader healthcare trends.

Cardiovascular Disease (Dominant) vs. Cancer (Emerging)

Cardiovascular disease represents the dominant force in the South Korea transradial access-devices market, characterized by a variety of interventional techniques that focus on heart-related ailments. The established presence of these devices is largely supported by high-volume cardiovascular procedures, demanding reliability and advanced technology. On the other hand, cancer treatment is an emerging segment, increasingly gaining traction due to advancements in treatment options and improved patient outcomes. This area is marked by innovative approaches for accessing tumors via transradial methods, reflecting the changing landscape of oncological interventions. The dual focus on both segments signifies a comprehensive approach to addressing critical health issues in South Korea.

### By End User: Hospitals (Largest) vs. Clinics (Fastest-Growing)

The market share distribution within the South Korea transradial access-devices market indicates that hospitals dominate due to their extensive utilization of these devices for various procedures. With a larger patient volume and a wider range of healthcare services, hospitals play a critical role in driving demand. In contrast, clinics, while representing a smaller share, are experiencing rapid adoption, driven by the increasing preference for minimally invasive procedures and rising patient awareness.

Growth trends for the segment reveal a robust expansion in both hospitals and clinics, with hospitals benefiting from technological advancements and increased investments in healthcare facilities. Meanwhile, clinics are emerging as a pivotal segment, leveraging their agility and focused patient care to capture market share. The growing trend towards outpatient procedures and rising healthcare expenditure further contribute to the clinics' fastest growth trajectory.

Hospitals (Dominant) vs. Clinics (Emerging)

Hospitals remain the dominant end user in the South Korea transradial access-devices market, characterized by their established infrastructure and comprehensive patient care capabilities. They utilize an extensive range of transradial access devices to improve patient outcomes and procedural efficiency. Conversely, clinics are emerging rapidly, catering to a specific patient demographic that favors outpatient services. This segment emphasizes convenience and quicker recovery times, capturing the attention of patients seeking less invasive options. The adoption of transradial access devices in clinics is supported by growing healthcare trends emphasizing patient-centered care, making them a significant player poised for further growth.

## Competitive Benchmarking

The transradial access-devices market in South Korea is characterized by a competitive landscape that is increasingly shaped by innovation and strategic partnerships. Key players such as Terumo Corporation (Japan), Boston Scientific Corporation (US), and Medtronic plc (Ireland) are actively pursuing growth through technological advancements and regional expansions. Terumo Corporation (Japan) has focused on enhancing its product portfolio with innovative access devices that cater to the growing demand for minimally invasive procedures. Meanwhile, Boston Scientific Corporation (US) emphasizes strategic collaborations to bolster its market presence, particularly in the Asia-Pacific region, which is witnessing a surge in interventional cardiology procedures. Medtronic plc (Ireland) appears to be concentrating on digital transformation initiatives, integrating advanced data analytics into its product offerings to improve patient outcomes and operational efficiency.The business tactics employed by these companies reflect a commitment to localizing manufacturing and optimizing supply chains to enhance responsiveness to market demands. The competitive structure of the market is moderately fragmented, with several players vying for market share. However, the collective influence of these key players is significant, as they drive innovation and set industry standards that smaller competitors often follow.

In September  Terumo Corporation (Japan) announced the launch of a new transradial access device designed to improve patient comfort and procedural efficiency. This strategic move is likely to strengthen Terumo's position in the market by addressing the growing preference for patient-centric solutions. The introduction of this device not only showcases Terumo's commitment to innovation but also aligns with the broader trend of enhancing patient experiences in medical procedures.

In August  Boston Scientific Corporation (US) entered into a partnership with a leading South Korean healthcare provider to expand its distribution network for transradial access devices. This collaboration is expected to enhance Boston Scientific's market penetration and facilitate access to its advanced technologies in the region. By leveraging local expertise, the company aims to tailor its offerings to meet specific regional needs, thereby solidifying its competitive edge.

In October  Medtronic plc (Ireland) unveiled a new digital platform that integrates its transradial access devices with real-time data analytics capabilities. This initiative is indicative of Medtronic's strategic focus on digital health solutions, which are becoming increasingly vital in the healthcare landscape. By providing healthcare professionals with actionable insights, Medtronic is likely to enhance procedural outcomes and foster greater adoption of its devices.

As of November  the competitive trends in the transradial access-devices market are heavily influenced by digitalization, sustainability, and the integration of artificial intelligence (AI). Strategic alliances are playing a crucial role in shaping the current landscape, as companies seek to combine resources and expertise to drive innovation. Looking ahead, it is anticipated that competitive differentiation will increasingly pivot from price-based strategies to a focus on technological advancements, supply chain reliability, and the ability to deliver superior patient outcomes.

## Recent News & Developments

In South Korea, the Transradial Access Devices Market has recently experienced several notable developments. As of September 2023, Abbott launched a new line of radial access devices designed for enhanced patient outcomes in catheterizations, indicating a shift towards less invasive techniques in cardiovascular procedures. Meanwhile, Medtronic focused on expanding its product portfolio with innovative designs aimed at improving procedural efficiency. The market has seen a strong uptick due to growing demand for minimally invasive surgery options, which has spurred competition among major players like Stryker and Boston Scientific.

Furthermore, there have been significant investments in Research and Development efforts, with Terumo and AngioDynamics making strides in advanced technologies for transradial access. In addition, notable acquisitions are shaping the landscape merger between Merit Medical Systems and a prominent South Korean device firm in June 2023 is poised to enhance market share and capabilities. Overall, the South Korea Transradial Access Devices Market remains dynamic, with companies striving to leverage technological advancements while adapting to regulatory changes and increased healthcare demands.

## Report Scope

| MARKET SIZE 2024 | 43.15(USD Million) |
| --- | --- |
| MARKET SIZE 2025 | 46.18(USD Million) |
| MARKET SIZE 2035 | 91.01(USD Million) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 7.02% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| Market Forecast Period | 2025 - 2035 |
| Historical Data | 2019 - 2024 |
| Market Forecast Units | USD Million |
| Key Companies Profiled | Terumo Corporation (JP), Boston Scientific Corporation (US), Medtronic plc (IE), Abbott Laboratories (US), B. Braun Melsungen AG (DE), Cardinal Health, Inc. (US), Johnson & Johnson (US), Cook Medical Incorporated (US) |
| Segments Covered | Product, Application, Disease Area, End User |
| Key Market Opportunities | Growing demand for minimally invasive procedures drives innovation in the transradial access-devices market. |
| Key Market Dynamics | Rising demand for minimally invasive procedures drives innovation in transradial access-devices within South Korea's healthcare sector. |
| Countries Covered | South Korea |

## Frequently Asked Questions

**Q: What was the market valuation of transradial access-devices in South Korea in 2024?**
A: The market valuation was $43.15 Million in 2024.

**Q: What is the projected market valuation for transradial access-devices in South Korea by 2035?**
A: The projected valuation for 2035 is $91.01 Million.

**Q: What is the expected CAGR for the South Korea transradial access-devices market during the forecast period 2025 - 2035?**
A: The expected CAGR during this period is 7.02%.

**Q: Which companies are considered key players in the South Korea transradial access-devices market?**
A: Key players include Terumo Corporation, Boston Scientific Corporation, Medtronic plc, Abbott Laboratories, B. Braun Melsungen AG, Cardinal Health, Inc., Johnson & Johnson, and Cook Medical Incorporated.

**Q: What were the revenue figures for catheters in the South Korea transradial access-devices market?**
A: Revenue for catheters was $25.89 Million in 2024 and is projected to reach $54.12 Million by 2035.

**Q: How much revenue is expected from guidewires in the South Korea transradial access-devices market?**
A: Guidewires generated $17.26 Million in 2024 and are anticipated to grow to $36.89 Million by 2035.

**Q: What applications are driving the South Korea transradial access-devices market?**
A: Key applications include drug administration, which was valued at $25.89 Million in 2024, and blood transfusion, projected to reach $37.01 Million by 2035.

**Q: Which disease areas are contributing to the growth of the South Korea transradial access-devices market?**
A: The market is driven by cardiovascular disease, cancer, and strokes, with revenues of $15.0 Million, $12.0 Million, and $16.15 Million in 2024, respectively.

**Q: What are the revenue expectations for hospitals and clinics in the South Korea transradial access-devices market?**
A: Hospitals generated $30.0 Million in 2024, while clinics contributed $13.15 Million, with both segments expected to grow by 2035.

**Q: How does the South Korea transradial access-devices market compare to other regions?**
A: While specific regional comparisons are not provided, the growth trajectory and key players suggest a competitive landscape in South Korea.


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/south-korea-transradial-access-devices-market-56080*